Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, Yang H, Liu C, Kam LY, Tan XXE, Chien N, Trinh S, Henry L, Stave CD, Hosaka T, Cheung RC, Nguyen MH.
Ye Q, et al.
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12.
Lancet Gastroenterol Hepatol. 2020.
PMID: 32413340
The incidence of NAFLD in the non-obese population (without NAFLD at baseline) was 24.6 (95% CI 13.4-39.2) per 1000 person-years. Among people with non-obese or lean NALFD, 39.0% (95% CI 24.1-56.3) had non-alcoholic steatohepatitis, 29.2% (21.9-37.9) had significant fibros …
The incidence of NAFLD in the non-obese population (without NAFLD at baseline) was 24.6 (95% CI 13.4-39.2) per 1000 person-years. Among peop …